The paper examines the potential of artificial intelligence (AI) in parsing text and conducting sentiment analysis to identify early markers of mental health and neurodegenerative disorders. Through the analysis of textual data, we investigate whether AI can provide a noninvasive, continuous, and objective complement to traditional diagnostic practices.
Background: the early detection of mental health (such as depression, anxiety, psychotic disorders, Alzheimer’s disease and dementia) and neurodegenerative disorders (like Parkinson’s disease) remains a critical challenge in clinical practice. Traditional diagnostic methods rely on clinical evaluations that may be subjective and episodic. Recent advancements in AI and natural language processing (NLP) have opened new avenues for precognitive health assessments, suggesting that variations in language and expressed sentiments in written text can serve as potential biomarkers for these conditions.
Materials and Methods: the research used a dataset comprising various forms of textual data, including anonymized social media interactions, transcripts from patient interviews, and electronic health records. NLP algorithms were deployed to parse the text, and machine learning models were trained to identify language patterns and sentiment changes. The study also incorporated a sentiment analysis to gauge emotional expression, a key component of mental health diagnostics.
Results: the AI models were able to identify language use patterns and sentiment shifts that correlated with clinically validated instances of mental health symptoms and neurodegenerative conditions. Notably, the models detected an increased use of negative a ect words, a higher frequency of first-person singular pronouns, and a decrease in future tense in individuals with depression. For neurode-generative conditions, there was a notable decline in language complexity and semantic coherence over time.
Conclusions: the implemented pipeline of AI-parsed text and sentiment analysis appears to be a promising tool for the early detection and ongoing monitoring of mental health and neurodegenerative disorders. However, these methods are supplementary and cannot replace the nuanced clinical evaluation process. Future research must refine the AI algorithms to account for linguistic diversity and context, while also addressing ethical considerations regarding data use and privacy. The integration of AI tools in clinical settings necessitates a multidisciplinary approach, ensuring that technological advancements align with patient-centered care and ethical standards.